Market Pulse LIVECAST Terminal Politics Macro Calendar/FX

More

About Why SquawkNews Schedule Prediction Markets Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Politics Macro Calendar/FX About Why SquawkNews Schedule Prediction Markets Disclosure Wire Crypto Search

Live News EQUITY L impact Jul 02, 2026, 04:11 AM UTC

UBS To Trial US Banking Services In Push For Wealthy American Clients – FT

READ HERE

SQUAWKNEWS Updated Jul 02, 2026, 04:11 AM UTC

READ HERE

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

South Korea Foreign Ministry: Will Again Be Contacting US House Judiciary Committee On The Probe On Coupang South Korea Foreign Ministry: Will Again Be Contacting US House Judiciary Committee On The Probe On Coupang L impact | EQUITY | Jul 02, 2026, 05:38 AM UTC Apple tells suppliers to plan 10M folding iPhones this year - Nikkei. $AAPL Apple tells suppliers to plan 10M folding iPhones this year - Nikkei. $AAPL L impact | EQUITY | Jul 02, 2026, 05:34 AM UTC HSBC Raises Adobe To Buy From Hold; Raises Target Price To $308 From $282 HSBC Raises Adobe To Buy From Hold; Raises Target Price To $308 From $282 L impact | EQUITY | Jul 02, 2026, 05:27 AM UTC Morning Juice - Europe Session Prep Morning Juice - Europe Session Prep L impact | EQUITY | Jul 02, 2026, 05:20 AM UTC SurgePays (SURG) Stock Surges Over 61% After Hours: Why Is It Moving? SurgePays Inc. (NASDAQ: SURG ) shares jumped 61.15% to $0.67 in after-hours trading on Wednesday, after the Tennessee-based wireless and fintech company amended its agreement with L impact | EQUITY | Jul 02, 2026, 05:05 AM UTC Novartis Receives European Commission Approval For Itvisma® Gene Therapy For Spinal Muscular Atrophy Itvisma Is A One-Time Fixed-Dose Gene Therapy For SMA Gene Replacement Therapies Now Eligible Across All Age Groups In The EU STEER And STRENGTH Studies Show Clinically Meaningful L impact | EQUITY | Jul 02, 2026, 05:03 AM UTC